BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 34733320)

  • 1. Development of a 3 RNA Binding Protein Signature for Predicting Prognosis and Treatment Response for Glioblastoma Multiforme.
    Sun R; Pan Y; Mu L; Ma Y; Shen H; Long Y
    Front Genet; 2021; 12():768930. PubMed ID: 34733320
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
    Huang QR; Li JW; Pan XB
    Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new prognostic model for glioblastoma multiforme based on coagulation-related genes.
    Zhou M; Deng Y; Fu Y; Liang R; Liu Y; Liao Q
    Transl Cancer Res; 2023 Oct; 12(10):2898-2910. PubMed ID: 37969372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme.
    Yu Z; Yang H; Song K; Fu P; Shen J; Xu M; Xu H
    Front Oncol; 2022; 12():938679. PubMed ID: 35982954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a prognostic model based on RNA binding proteins in patients with esophageal cancer.
    Du H; Li Y; Pang S; Enofe I; Pallante P; Zhu L; Hang J; Chen L
    J Thorac Dis; 2023 Nov; 15(11):6178-6191. PubMed ID: 38090289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma.
    Wang M; Huang S; Chen Z; Han Z; Li K; Chen C; Wu G; Zhao Y
    BMC Cancer; 2020 Nov; 20(1):1136. PubMed ID: 33228611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The construction and validation of an RNA binding protein-related prognostic model for bladder cancer.
    Chen F; Wang Q; Zhou Y
    BMC Cancer; 2021 Mar; 21(1):244. PubMed ID: 33685397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses.
    Cao M; Cai J; Yuan Y; Shi Y; Wu H; Liu Q; Yao Y; Chen L; Dang W; Zhang X; Xiao J; Yang K; He Z; Yao X; Cui Y; Zhang X; Bian X
    Cancer Biol Med; 2019 Aug; 16(3):595-605. PubMed ID: 31565488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients.
    Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F
    J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of Nine-RNA Binding Protein Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma.
    Zhong W; Huang C; Lin J; Zhu M; Zhong H; Chiang MH; Chiang HS; Hui MS; Lin Y; Huang J
    Front Genet; 2020; 11():568192. PubMed ID: 33133154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database.
    Lei CG; Jia XY; Sun WJ
    Yi Chuan; 2021 Jul; 43(7):665-679. PubMed ID: 34284982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Five-lncRNAs Signature-Derived Risk Score Based on TCGA and CGGA for Glioblastoma: Potential Prospects for Treatment Evaluation and Prognostic Prediction.
    Niu X; Sun J; Meng L; Fang T; Zhang T; Jiang J; Li H
    Front Oncol; 2020; 10():590352. PubMed ID: 33392085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological functions and prognostic value of RNA Binding Proteins in clear cell Renal Cell Carcinoma.
    Zhu Z; He A; Lin L; Xu C; Cai T; Lin J
    J Cancer; 2020; 11(22):6591-6600. PubMed ID: 33046980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Prognosis-Related RNA-Binding Proteins to Reveal the Role of RNA-Binding Proteins in the Progression and Prognosis of Colon Cancer.
    Ding Y; Fang L; Yang XP; Zou Q
    Int J Gen Med; 2021; 14():6795-6805. PubMed ID: 34703285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a new RNA-binding proteins-based signature for prognostic prediction in gastric cancer.
    Wang Y; Ye W; Tian G; Zhang Y
    Medicine (Baltimore); 2022 Feb; 101(8):e28901. PubMed ID: 35212295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Hypoxia Prognostic Signature in Glioblastoma Multiforme Based on Bulk and Single-Cell RNA-Seq.
    Ahmed YB; Ababneh OE; Al-Khalili AA; Serhan A; Hatamleh Z; Ghammaz O; Alkhaldi M; Alomari S
    Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and Validation of a Novel RNA-Binding Protein-Related Gene-Based Prognostic Model for Multiple Myeloma.
    Wang W; Xu SW; Zhu XY; Guo QY; Zhu M; Mao XL; Chen YH; Li SW; Luo WD
    Front Genet; 2021; 12():665173. PubMed ID: 33981333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of an RNA-Binding Protein-Related Prognostic Model for Pancreatic Adenocarcinoma Based on TCGA and GTEx Databases.
    Wen X; Shao Z; Chen S; Wang W; Wang Y; Jiang J; Ma Q; Zhang L
    Front Genet; 2020; 11():610350. PubMed ID: 33584809
    [No Abstract]   [Full Text] [Related]  

  • 19. Development and validation of a nomogram with an autophagy-related gene signature for predicting survival in patients with glioblastoma.
    Wang Z; Gao L; Guo X; Feng C; Lian W; Deng K; Xing B
    Aging (Albany NY); 2019 Dec; 11(24):12246-12269. PubMed ID: 31844032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and validation of an immune-based prognostic score model in glioblastoma.
    Qin Z; Zhang X; Chen Z; Liu N
    Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.